Opens in a new tab
English

Useful Links

What HLTH USA 2026 Revealed About AI, Trust, and Life Sciences

HLTH USA 2026 took place at The Venetian Expo Center in Las Vegas from November 15 to 18. The event drew more than 12,250 attendees, including over 4,400 C-suite leaders. This year’s theme, “The Age of Intelligent Healthcare,” shaped four days of programming. Sessions covered AI and emerging technology, diagnostics, care delivery, health policy, and pharma and life sciences.

Kelleen Kaden represented Vistatec’s Life Sciences team throughout the week. She met with pharma, biotech, and health technology leaders across the event. As a result, she returned with a clear view of where AI, patient engagement, and global access are heading. These themes stood out most.

AI Is Now the Baseline

Across the show floor, AI no longer needed an introduction. In fact, several exhibitors had dropped “AI” from their names because attendees simply assumed it. Meanwhile, one company reported that healthcare AI spending reached $3.7 billion in 2026. That marks a 250% rise in a single year.

However, enthusiasm came with sharper questions about value. Google Cloud found that 40% of healthcare organizations see unpredictable costs as a risk to AI projects. Consequently, buyers wanted proof of outcomes rather than polished claims. For life sciences teams, this shift rewards partners who can demonstrate measurable quality and cost control.

Agentic AI Moves Into Real Workflows

Agentic AI drove many of the week’s biggest announcements. OpenAI expanded ChatGPT for Healthcare with agents that handle multi-step workflows. It also shared plans to test computer-use agents with several companies. Similarly, another exhibitor announced that its agentic AI now supports a developer of obesity and metabolic medicines.

These agents now complete tasks across systems on a user’s behalf. Therefore, the content and data that feed them must stay accurate in every language they touch. Vistatec’s LLM and AI Agents services help organizations adapt, test, and deploy agents for multilingual markets. In addition, high-quality AI data services give those agents a reliable foundation.

Trust Becomes the Deciding Factor

Trust surfaced in nearly every conversation about AI. For example, the “Can Healthcare Trust AI?” session explored what clinicians and patients need before relying on AI. PwC research shared during the week found that 49% of patients trust technology for primary care.

For regulated industries, trust depends on transparent governance and rigorous quality checks. Many speakers also stressed that people must stay in control of high-stakes decisions. Vistatec supports this approach through structured AI Governance frameworks. Likewise, expert Quality Evaluations of AI test model output for accuracy and safety across languages.

Patient Communication Must Feel Relevant

Patient engagement drew attention from payers, providers, and manufacturers alike. Lirio research found that 58% of patients say provider and health plan communications do not consistently feel relevant. Meanwhile, new tools at the event targeted medication adherence, GLP-1 support, and between-visit care.

Relevance also depends on language and culture. A medication reminder only works when patients understand it and recognize their own needs in it. For this reason, transcreation plays an important role in patient materials, where tone and cultural context shape outcomes.

Pharma Joins the Wider Healthcare Conversation

HLTH stands apart because pharma leaders meet directly with payers, health systems, and employers. The Pharma & Life Sciences Zone hosted discussions on drug development, precision medicine, and patient access. Additionally, GLP-1 economics and drug repurposing featured prominently, including new work between OpenEvidence and Every Cure.

These cross-sector conversations carry clear implications for global launches. Partnerships now span pharma, payers, and technology providers across many regions. As a result, consistent terminology and compliant content become essential at every stage. Life sciences leaders increasingly look for partners who combine regulatory awareness with proven AI capability.

Looking Ahead to 2027

HLTH USA 2026 confirmed that AI now shapes every part of healthcare. Life sciences companies must therefore scale it responsibly and consistently across their global markets. If you want to explore what this means for your organization, speak with one of our experts.

HLTH returns to Las Vegas from October 17 to 20, 2027. In the meantime, explore our case studies to see how Vistatec delivers trusted multilingual content for life sciences.

Do you want to know more?

Talk To Us